Search Results
CMS achieved improper payment rate reductions in Medicare Fee-For-Service (FFS), Medicare Part C, Medicare Part D, Medicaid, and Children’s Health Insurance Program
CMS has implemented several initiatives to address improper payments, resulting in this being the first year in improper payment reporting history that the Medicare Fee-For-Service (FFS), Medicare Part C, Medicare Part D, Medicaid and Children’s Health Insurance Program achieved reductions in all five programs’ improper payment rates.
Fact sheetContract Year (CY) 2020 Medicare Advantage and Part D Flexibility Proposed Rule (CMS-4185-P)
Fact sheet
Speech: Remarks by Administrator Seema Verma at the America’s Health Insurance Plans (AHIP) 2018 National Conference on Medicare
Remarks by Administrator Seema Verma at the America’s Health Insurance Plans (AHIP) 2018 National Conference on Medicare
Press releaseCMS announces new streamlined user experience for Medicare beneficiaries
Today, the Centers for Medicare & Medicaid Services (CMS) announced a multi-year initiative that will empower patients and update Medicare resources to meet beneficiaries’ expectation of a more personalized customer experience.
Press release2019 Medicare Advantage and Part D Prescription Drug Program Landscape
The Centers for Medicare & Medicaid Services (CMS) is committed to strengthening and modernizing the Medicare Advantage and Part D prescription drug programs by providing additional flexibilities and efficiencies so that plan sponsors are encouraged to provide innovative benefits and plan offerings that provide Medicare enrollees with high quality healthcare services.
Fact sheetMedicare Advantage premiums continue to decline while plan choices and benefits increase in 2019
Press release
Medicare Advantage Prior Authorization and Step Therapy for Part B Drugs
Today, the Centers for Medicare & Medicaid Services (CMS) introduced much-needed competition and negotiation into the market for physician-administered and other Part B medications that will result in better deals and lower drug costs for patients. As part of the agency’s ongoing activities to deliver on President Trump’s promises outlined in his American Patients First Blueprint, CMS will provide Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs in a way that lowers costs and improves the quality of care for Medicare beneficiaries.
Fact sheetCMS empowers patients with more choices and takes action to lower drug prices
Agency is providing flexibility through private sector tools to negotiate lower prescription drug prices on behalf of beneficiaries.
Press releaseSPEECH: Remarks by Administrator Seema Verma at the ONC Interoperability Forum in Washington, DC
(As prepared for delivery – August 6, 2018)
Press release